What We Do
How We Operate
How We Do It!
-
AI and ML Integration: We utilize advanced AI and ML algorithms to analyze complex biological data, revealing insights that were previously unattainable.
-
Transcriptomic and Proteomic Analysis: By examining the intricate details of gene expression and protein interactions, we identify novel targets that can lead to the development of new therapies.
-
Pathway Validation: Our technology not only discovers new targets but also validates existing pathways, ensuring the reliability and effectiveness of potential treatments.
We have developed a range of novel approaches
Our I3 platform (“Intuitive Informed Intelligence”) is proven. Our work over the last 18 years demonstrates clearly that these non-linear discovery tools are highly suited to the analysis of complex biological data
​
Outcomes
The I3 platform identifies the most influential markers in a biological system, confirms their direction of influence and the relevant known drugs or chemical library hits: we find the molecular drivers of a given phenotype, leading to identification of new drug and diagnostic targets as well as new applications for existing drugs.
​
How We Work with Our Clients
-
Collaborative working on a shared risk and reward basis
-
Contract – a Fee for the service provided
-
Partnership – to develop Intellectual Property created by Intellomx technology, on a Licensing or Joint Venture basis